PrintThe Burrill Report
The Burrill Report (April 15, 2013): Precision Medicine Meets Antibiotics (.MP3,20.26 Mb)
Last month, the Centers for Disease Control and Prevention sounded the alarm on “nightmare bacteria” that pose an increasing threat because of their resistance to the strongest weapons in today’s antibiotics arsenal. David Martin, CEO of AvidBiotics, says we’ve created the problem through the ubiquitous use of broad spectrum antibiotics. He thinks the answer to attacking resistant strains of bacteria lies in the use of extremely narrow spectrum drugs. We talked to Martin about Avidocin, his company’s protein antibacterial technology, and how we are moving toward highly targeted precision medicine to combat these infections.
April 11, 2013
http://www.burrillreport.com/article-precision_medicine_meets_antibiotics.html
INFECTIOUS DISEASE
Precision Medicine Meets Antibiotics
Podcast: April 15, 2013[Please login to post comments]
- Chimerix and Omthera Go Public in Upsized Offerings
One company prices in its target range, the other at a significant discount. Read More - Obama Budget Raises Ire of PhRMA, BIO
Trade groups blast proposal as harmful to innovation, job growth, and patients. Read More - Seeking Drug Savings, But Risking Safety
Study illuminates ways in which Americans are trimming their prescription drug costs. Read More - GSK Offers $1 Million Prize for Brain Breakthroughs
Competition seeks to uncover new techniques and device-based brain therapies. Read More - VistaGen Secures $36 Million
European investor provides funds to accelerate drug rescue programs. Read More - CDC, BARDA Enlist Venter Institute to Combat H7N9
Synthetic Genomics Vaccines working with Novartis to synthesize genes of new virus. Read More - Gene Mutation Could Direct Prostate Cancer Care
Carrying a BRCA2 mutation indicates poor survival for men with prostate cancer. Read More - Inovio and U.S. Army Receive $3.5 Million Biodefense Grant
Money will be used to advance electroporation delivery platform for multiple vaccines. Read More - Practice Makes Perfect
Surgeons use personalized organ model to improve patient outcomes. Read More - GSK Trial Shows Encouraging Results for Duchenne MD
Exon-skipping technology moves ahead after mid-stage study validation. Read More
.gif)
